lomustine has been researched along with Brain Stem Neoplasms, Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pillai, A | 1 |
| Rajeev, K | 1 |
| Chandi, S | 1 |
| Unnikrishnan, M | 1 |
| Glas, M | 1 |
| Hennemann, B | 1 |
| Hirschmann, B | 1 |
| Marienhagen, J | 1 |
| Schmidt-Wolf, I | 1 |
| Herrlinger, U | 1 |
| Bogdahn, U | 1 |
| Hau, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase I/II Study of Lutathera in Pediatric and Young Adult Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Express Somatostatin Type2A Receptors and Demonstrate Uptake on DOTATATE PET[NCT05278208] | Phase 1/Phase 2 | 65 participants (Anticipated) | Interventional | 2022-11-21 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for lomustine and Brain Stem Neoplasms, Primary
| Article | Year |
|---|---|
Intrinsic brainstem choroid plexus papilloma. Case report.
Topics: Antineoplastic Agents, Alkylating; Brain Stem Neoplasms; Choroid Plexus Neoplasms; Female; Glioma; H | 2004 |
Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Brain Stem N | 2008 |